Guest guest Posted September 1, 2009 Report Share Posted September 1, 2009 There is a good piece about lifestyle considerations if a patient chooses not to do treatment. > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Tue, 1 Sep 2009 18:16:33 -0400 > > > > Hello, > > The following items have been posted to www.hcvadvocate.org and > www.hbvadvocate.org. > > > > ***Action Alert: > Help the National Viral Hepatitis Roundtable fill the room with > congressional staffers. Click here > > > *** HCV Advocate Newsletter: September 2009 > Download English printable version-------- > > > In This Issue: > > Vibrio Vulnificus > Alan Franciscus, Editor-in-Chief > > HealthWise: Choosing Not to Treat Hepatitis C > Lucinda Porter, RN > > HCV & Native Americans > Alan Franciscus, Editor-in-Chief > > HIV/HCV Coinfection Updates from the International AIDS Society Conference > > Liz Highleyman > > Blueberries, Asparagus and HCV > C.D. Mazoff, PhD > > ***HBV Journal Review: September 2009 > by Kukka > > ***HEPATITIS JOURNAL REVIEW: August 25 , 2009 Volume 6, Issue 8 > by Liz HighleymanTo download pdf version click here > > In This Issue: > > Genetic Variation Predicts Response > Statins Active Against HCV > Steatosis > Cardiovascular Risk > > HCV Transmission among HIV Positive Gay Men > > > > ***Reporting Drug Side Effects > by Alan Franciscus > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > > Week Ending: August 29, 2009 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > Novel Targets for specific therapy of hepatitis C > U.S. probes Roche, Glaxo diet drug over liver injury > Salix Pharmaceuticals Announces FDA Acceptance for Filing and Priority > Review Designation for Rifaximin NDA for the Maintenance of Remission of > Hepatic Encephalopathy > Court to rule on whether hepatitis cases can proceed > Fat In the Liver -- Not the Belly -- Is a Better Marker for Disease Risk > Bradley Corp Releases Results of National Hand Washing Survey > Is endotoxin receptor CD14 rs2569190/C-159T gene correlated with chronic > hepatitis C? > VA Negligence Suits Likely after Botched Colonoscopies > In HIV-HCV Coinfection, HCV Clearance Reduces Overall Mortality > China donor drive aims to end prisoner organ trade > Lower Tacrolimus Dose Is Suitable For Living Donor Liver Transplantation > With Small-For-Size Graft > A Potential Therapeutic Agent For Hepatic Fibrosis > The Flomax incident > Study of Racial Disparity in Patients Undergoing Liver Transplantation for > Hepatitis B > Shortage of Donor Livers - An Every Day Dilemma for UK Doctors > > > *** Be sure to check out the latest event notices at both the HCV and HBV > Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not > reply to this email. Questions and/or comments can be directed to > alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 1, 2009 Report Share Posted September 1, 2009 There is a good piece about lifestyle considerations if a patient chooses not to do treatment. > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Tue, 1 Sep 2009 18:16:33 -0400 > > > > Hello, > > The following items have been posted to www.hcvadvocate.org and > www.hbvadvocate.org. > > > > ***Action Alert: > Help the National Viral Hepatitis Roundtable fill the room with > congressional staffers. Click here > > > *** HCV Advocate Newsletter: September 2009 > Download English printable version-------- > > > In This Issue: > > Vibrio Vulnificus > Alan Franciscus, Editor-in-Chief > > HealthWise: Choosing Not to Treat Hepatitis C > Lucinda Porter, RN > > HCV & Native Americans > Alan Franciscus, Editor-in-Chief > > HIV/HCV Coinfection Updates from the International AIDS Society Conference > > Liz Highleyman > > Blueberries, Asparagus and HCV > C.D. Mazoff, PhD > > ***HBV Journal Review: September 2009 > by Kukka > > ***HEPATITIS JOURNAL REVIEW: August 25 , 2009 Volume 6, Issue 8 > by Liz HighleymanTo download pdf version click here > > In This Issue: > > Genetic Variation Predicts Response > Statins Active Against HCV > Steatosis > Cardiovascular Risk > > HCV Transmission among HIV Positive Gay Men > > > > ***Reporting Drug Side Effects > by Alan Franciscus > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > > Week Ending: August 29, 2009 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > Novel Targets for specific therapy of hepatitis C > U.S. probes Roche, Glaxo diet drug over liver injury > Salix Pharmaceuticals Announces FDA Acceptance for Filing and Priority > Review Designation for Rifaximin NDA for the Maintenance of Remission of > Hepatic Encephalopathy > Court to rule on whether hepatitis cases can proceed > Fat In the Liver -- Not the Belly -- Is a Better Marker for Disease Risk > Bradley Corp Releases Results of National Hand Washing Survey > Is endotoxin receptor CD14 rs2569190/C-159T gene correlated with chronic > hepatitis C? > VA Negligence Suits Likely after Botched Colonoscopies > In HIV-HCV Coinfection, HCV Clearance Reduces Overall Mortality > China donor drive aims to end prisoner organ trade > Lower Tacrolimus Dose Is Suitable For Living Donor Liver Transplantation > With Small-For-Size Graft > A Potential Therapeutic Agent For Hepatic Fibrosis > The Flomax incident > Study of Racial Disparity in Patients Undergoing Liver Transplantation for > Hepatitis B > Shortage of Donor Livers - An Every Day Dilemma for UK Doctors > > > *** Be sure to check out the latest event notices at both the HCV and HBV > Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not > reply to this email. Questions and/or comments can be directed to > alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 1, 2009 Report Share Posted September 1, 2009 There is a good piece about lifestyle considerations if a patient chooses not to do treatment. > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Tue, 1 Sep 2009 18:16:33 -0400 > > > > Hello, > > The following items have been posted to www.hcvadvocate.org and > www.hbvadvocate.org. > > > > ***Action Alert: > Help the National Viral Hepatitis Roundtable fill the room with > congressional staffers. Click here > > > *** HCV Advocate Newsletter: September 2009 > Download English printable version-------- > > > In This Issue: > > Vibrio Vulnificus > Alan Franciscus, Editor-in-Chief > > HealthWise: Choosing Not to Treat Hepatitis C > Lucinda Porter, RN > > HCV & Native Americans > Alan Franciscus, Editor-in-Chief > > HIV/HCV Coinfection Updates from the International AIDS Society Conference > > Liz Highleyman > > Blueberries, Asparagus and HCV > C.D. Mazoff, PhD > > ***HBV Journal Review: September 2009 > by Kukka > > ***HEPATITIS JOURNAL REVIEW: August 25 , 2009 Volume 6, Issue 8 > by Liz HighleymanTo download pdf version click here > > In This Issue: > > Genetic Variation Predicts Response > Statins Active Against HCV > Steatosis > Cardiovascular Risk > > HCV Transmission among HIV Positive Gay Men > > > > ***Reporting Drug Side Effects > by Alan Franciscus > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > > Week Ending: August 29, 2009 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > Novel Targets for specific therapy of hepatitis C > U.S. probes Roche, Glaxo diet drug over liver injury > Salix Pharmaceuticals Announces FDA Acceptance for Filing and Priority > Review Designation for Rifaximin NDA for the Maintenance of Remission of > Hepatic Encephalopathy > Court to rule on whether hepatitis cases can proceed > Fat In the Liver -- Not the Belly -- Is a Better Marker for Disease Risk > Bradley Corp Releases Results of National Hand Washing Survey > Is endotoxin receptor CD14 rs2569190/C-159T gene correlated with chronic > hepatitis C? > VA Negligence Suits Likely after Botched Colonoscopies > In HIV-HCV Coinfection, HCV Clearance Reduces Overall Mortality > China donor drive aims to end prisoner organ trade > Lower Tacrolimus Dose Is Suitable For Living Donor Liver Transplantation > With Small-For-Size Graft > A Potential Therapeutic Agent For Hepatic Fibrosis > The Flomax incident > Study of Racial Disparity in Patients Undergoing Liver Transplantation for > Hepatitis B > Shortage of Donor Livers - An Every Day Dilemma for UK Doctors > > > *** Be sure to check out the latest event notices at both the HCV and HBV > Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not > reply to this email. Questions and/or comments can be directed to > alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 1, 2009 Report Share Posted September 1, 2009 There is a good piece about lifestyle considerations if a patient chooses not to do treatment. > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Tue, 1 Sep 2009 18:16:33 -0400 > > > > Hello, > > The following items have been posted to www.hcvadvocate.org and > www.hbvadvocate.org. > > > > ***Action Alert: > Help the National Viral Hepatitis Roundtable fill the room with > congressional staffers. Click here > > > *** HCV Advocate Newsletter: September 2009 > Download English printable version-------- > > > In This Issue: > > Vibrio Vulnificus > Alan Franciscus, Editor-in-Chief > > HealthWise: Choosing Not to Treat Hepatitis C > Lucinda Porter, RN > > HCV & Native Americans > Alan Franciscus, Editor-in-Chief > > HIV/HCV Coinfection Updates from the International AIDS Society Conference > > Liz Highleyman > > Blueberries, Asparagus and HCV > C.D. Mazoff, PhD > > ***HBV Journal Review: September 2009 > by Kukka > > ***HEPATITIS JOURNAL REVIEW: August 25 , 2009 Volume 6, Issue 8 > by Liz HighleymanTo download pdf version click here > > In This Issue: > > Genetic Variation Predicts Response > Statins Active Against HCV > Steatosis > Cardiovascular Risk > > HCV Transmission among HIV Positive Gay Men > > > > ***Reporting Drug Side Effects > by Alan Franciscus > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > > Week Ending: August 29, 2009 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > Novel Targets for specific therapy of hepatitis C > U.S. probes Roche, Glaxo diet drug over liver injury > Salix Pharmaceuticals Announces FDA Acceptance for Filing and Priority > Review Designation for Rifaximin NDA for the Maintenance of Remission of > Hepatic Encephalopathy > Court to rule on whether hepatitis cases can proceed > Fat In the Liver -- Not the Belly -- Is a Better Marker for Disease Risk > Bradley Corp Releases Results of National Hand Washing Survey > Is endotoxin receptor CD14 rs2569190/C-159T gene correlated with chronic > hepatitis C? > VA Negligence Suits Likely after Botched Colonoscopies > In HIV-HCV Coinfection, HCV Clearance Reduces Overall Mortality > China donor drive aims to end prisoner organ trade > Lower Tacrolimus Dose Is Suitable For Living Donor Liver Transplantation > With Small-For-Size Graft > A Potential Therapeutic Agent For Hepatic Fibrosis > The Flomax incident > Study of Racial Disparity in Patients Undergoing Liver Transplantation for > Hepatitis B > Shortage of Donor Livers - An Every Day Dilemma for UK Doctors > > > *** Be sure to check out the latest event notices at both the HCV and HBV > Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not > reply to this email. Questions and/or comments can be directed to > alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 1, 2009 Report Share Posted September 1, 2009 There is a good piece about lifestyle considerations if a patient chooses not to do treatment. > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Tue, 1 Sep 2009 18:16:33 -0400 > > > > Hello, > > The following items have been posted to www.hcvadvocate.org and > www.hbvadvocate.org. > > > > ***Action Alert: > Help the National Viral Hepatitis Roundtable fill the room with > congressional staffers. Click here > > > *** HCV Advocate Newsletter: September 2009 > Download English printable version-------- > > > In This Issue: > > Vibrio Vulnificus > Alan Franciscus, Editor-in-Chief > > HealthWise: Choosing Not to Treat Hepatitis C > Lucinda Porter, RN > > HCV & Native Americans > Alan Franciscus, Editor-in-Chief > > HIV/HCV Coinfection Updates from the International AIDS Society Conference > > Liz Highleyman > > Blueberries, Asparagus and HCV > C.D. Mazoff, PhD > > ***HBV Journal Review: September 2009 > by Kukka > > ***HEPATITIS JOURNAL REVIEW: August 25 , 2009 Volume 6, Issue 8 > by Liz HighleymanTo download pdf version click here > > In This Issue: > > Genetic Variation Predicts Response > Statins Active Against HCV > Steatosis > Cardiovascular Risk > > HCV Transmission among HIV Positive Gay Men > > > > ***Reporting Drug Side Effects > by Alan Franciscus > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > > Week Ending: August 29, 2009 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > Novel Targets for specific therapy of hepatitis C > U.S. probes Roche, Glaxo diet drug over liver injury > Salix Pharmaceuticals Announces FDA Acceptance for Filing and Priority > Review Designation for Rifaximin NDA for the Maintenance of Remission of > Hepatic Encephalopathy > Court to rule on whether hepatitis cases can proceed > Fat In the Liver -- Not the Belly -- Is a Better Marker for Disease Risk > Bradley Corp Releases Results of National Hand Washing Survey > Is endotoxin receptor CD14 rs2569190/C-159T gene correlated with chronic > hepatitis C? > VA Negligence Suits Likely after Botched Colonoscopies > In HIV-HCV Coinfection, HCV Clearance Reduces Overall Mortality > China donor drive aims to end prisoner organ trade > Lower Tacrolimus Dose Is Suitable For Living Donor Liver Transplantation > With Small-For-Size Graft > A Potential Therapeutic Agent For Hepatic Fibrosis > The Flomax incident > Study of Racial Disparity in Patients Undergoing Liver Transplantation for > Hepatitis B > Shortage of Donor Livers - An Every Day Dilemma for UK Doctors > > > *** Be sure to check out the latest event notices at both the HCV and HBV > Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not > reply to this email. Questions and/or comments can be directed to > alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 1, 2009 Report Share Posted September 1, 2009 There is a good piece about lifestyle considerations if a patient chooses not to do treatment. > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Tue, 1 Sep 2009 18:16:33 -0400 > > > > Hello, > > The following items have been posted to www.hcvadvocate.org and > www.hbvadvocate.org. > > > > ***Action Alert: > Help the National Viral Hepatitis Roundtable fill the room with > congressional staffers. Click here > > > *** HCV Advocate Newsletter: September 2009 > Download English printable version-------- > > > In This Issue: > > Vibrio Vulnificus > Alan Franciscus, Editor-in-Chief > > HealthWise: Choosing Not to Treat Hepatitis C > Lucinda Porter, RN > > HCV & Native Americans > Alan Franciscus, Editor-in-Chief > > HIV/HCV Coinfection Updates from the International AIDS Society Conference > > Liz Highleyman > > Blueberries, Asparagus and HCV > C.D. Mazoff, PhD > > ***HBV Journal Review: September 2009 > by Kukka > > ***HEPATITIS JOURNAL REVIEW: August 25 , 2009 Volume 6, Issue 8 > by Liz HighleymanTo download pdf version click here > > In This Issue: > > Genetic Variation Predicts Response > Statins Active Against HCV > Steatosis > Cardiovascular Risk > > HCV Transmission among HIV Positive Gay Men > > > > ***Reporting Drug Side Effects > by Alan Franciscus > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > > Week Ending: August 29, 2009 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > Novel Targets for specific therapy of hepatitis C > U.S. probes Roche, Glaxo diet drug over liver injury > Salix Pharmaceuticals Announces FDA Acceptance for Filing and Priority > Review Designation for Rifaximin NDA for the Maintenance of Remission of > Hepatic Encephalopathy > Court to rule on whether hepatitis cases can proceed > Fat In the Liver -- Not the Belly -- Is a Better Marker for Disease Risk > Bradley Corp Releases Results of National Hand Washing Survey > Is endotoxin receptor CD14 rs2569190/C-159T gene correlated with chronic > hepatitis C? > VA Negligence Suits Likely after Botched Colonoscopies > In HIV-HCV Coinfection, HCV Clearance Reduces Overall Mortality > China donor drive aims to end prisoner organ trade > Lower Tacrolimus Dose Is Suitable For Living Donor Liver Transplantation > With Small-For-Size Graft > A Potential Therapeutic Agent For Hepatic Fibrosis > The Flomax incident > Study of Racial Disparity in Patients Undergoing Liver Transplantation for > Hepatitis B > Shortage of Donor Livers - An Every Day Dilemma for UK Doctors > > > *** Be sure to check out the latest event notices at both the HCV and HBV > Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not > reply to this email. Questions and/or comments can be directed to > alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 23, 2009 Report Share Posted September 23, 2009 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Wed, 23 Sep 2009 16:06:26 -0400 > > > > Hello, > > The following items have been posted to www.hcvadvocate.org and > www.hbvadvocate.org. > > > > *** Hepatitis E (HEV) New! > > > > *** Short Term Disability Benefits New! > by Jacques Chambers, CLU, Benefits Consultant > > > *** Top 10 HCV Downloads of the Month (English & Spanish) New! > > *** Top 10 HBV Downloads of the Month New! > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > > Week Ending: September 19, 2009 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > Aspirin Could Diminish Hepatitis C Virus Replication > California bill would toughen training for tattoo artists > UPDATE 4-Dynavax shares soar as hepatitis B trials resume > Interferon Gene Variant Predicts Response to Hepatitis C Treatment > Celsion and the American Liver Foundation Partner to Promote Awareness of > Primary Liver Cancer and the ThermoDox Phase III Global HEAT Study to > Patients and Physicians > Editorial: Medical Inattention in New York Prisons > Physicians Are Talking About: The Million Med March on Washington > Engineering Team To Design And Study Liver Mimics > Aerobic Exercise Reduces Fatty Liver > ChemDiv And IDialog Nominate Novel Inhibitor Of Hepatitis C For Clinical > Development > Uninsured Americans hope reform brings health coverage > Hepatitis myths put Canadians at risk, survey warns > Genetic Hint for Ridding the Body of Hepatitis C > Are HBV Genotype B/B3 and C/C1 the Major Genotypes in Indonesia? > New Micro-Bland Embolization Technique with Embozene Microspheres to Be > Presented at the International Medical Conference in Lisbon, Portugal > Pa. approves over-the-counter syringe sales > Sticking it to the myths about hepatitis C > Researchers Isolates Liver Cancer Stem Cells Prior to Tumor Formation > Study links 45,000 U.S. deaths to lack of insurance > Give your kidneys a break: lose some weight > Cases of Liver Cancer Reduced in a Younger Population Vaccinated for HBV > Prime Minister Bayar Diagnosed to Have Hepatitis C > ICAAC: Hepatitis E Virus Finally Gets Some Respect > University Hospital Coventry unveils life-saving liver scanner > > *** Be sure to check out the latest event notices at both the HCV and HBV > Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not > reply to this email. Questions and/or comments can be directed to > alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 23, 2009 Report Share Posted September 23, 2009 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Wed, 23 Sep 2009 16:06:26 -0400 > > > > Hello, > > The following items have been posted to www.hcvadvocate.org and > www.hbvadvocate.org. > > > > *** Hepatitis E (HEV) New! > > > > *** Short Term Disability Benefits New! > by Jacques Chambers, CLU, Benefits Consultant > > > *** Top 10 HCV Downloads of the Month (English & Spanish) New! > > *** Top 10 HBV Downloads of the Month New! > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > > Week Ending: September 19, 2009 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > Aspirin Could Diminish Hepatitis C Virus Replication > California bill would toughen training for tattoo artists > UPDATE 4-Dynavax shares soar as hepatitis B trials resume > Interferon Gene Variant Predicts Response to Hepatitis C Treatment > Celsion and the American Liver Foundation Partner to Promote Awareness of > Primary Liver Cancer and the ThermoDox Phase III Global HEAT Study to > Patients and Physicians > Editorial: Medical Inattention in New York Prisons > Physicians Are Talking About: The Million Med March on Washington > Engineering Team To Design And Study Liver Mimics > Aerobic Exercise Reduces Fatty Liver > ChemDiv And IDialog Nominate Novel Inhibitor Of Hepatitis C For Clinical > Development > Uninsured Americans hope reform brings health coverage > Hepatitis myths put Canadians at risk, survey warns > Genetic Hint for Ridding the Body of Hepatitis C > Are HBV Genotype B/B3 and C/C1 the Major Genotypes in Indonesia? > New Micro-Bland Embolization Technique with Embozene Microspheres to Be > Presented at the International Medical Conference in Lisbon, Portugal > Pa. approves over-the-counter syringe sales > Sticking it to the myths about hepatitis C > Researchers Isolates Liver Cancer Stem Cells Prior to Tumor Formation > Study links 45,000 U.S. deaths to lack of insurance > Give your kidneys a break: lose some weight > Cases of Liver Cancer Reduced in a Younger Population Vaccinated for HBV > Prime Minister Bayar Diagnosed to Have Hepatitis C > ICAAC: Hepatitis E Virus Finally Gets Some Respect > University Hospital Coventry unveils life-saving liver scanner > > *** Be sure to check out the latest event notices at both the HCV and HBV > Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not > reply to this email. Questions and/or comments can be directed to > alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 23, 2009 Report Share Posted September 23, 2009 Could someone please explain this to me. Is it just a site to go to in order to get the information thats listed. I guess I just don't understand, I feel stupid for asking but I don't know all the places to get info yet, other than here. Maybe if I read it in the morning it will make more since to me. Goodnight to all. Spots ________________________________ From: Glenn <grisley6315@...> Sent: Wednesday, September 23, 2009 9:48:36 PM Subject: Fwd: HCV Advocate Email Alert  > From: " www.hcvadvocate. org " <root@... te.org> > <emailalertlist (DOT) hcvadvocate. org> > Subject: HCV Advocate Email Alert > Date: Wed, 23 Sep 2009 16:06:26 -0400 > > > > Hello, > > The following items have been posted to www.hcvadvocate. org and > www.hbvadvocate. org. > > > > *** Hepatitis E (HEV) New! > > > > *** Short Term Disability Benefits New! > by Jacques Chambers, CLU, Benefits Consultant > > > *** Top 10 HCV Downloads of the Month (English & Spanish) New! > > *** Top 10 HBV Downloads of the Month New! > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > > Week Ending: September 19, 2009 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > Aspirin Could Diminish Hepatitis C Virus Replication > California bill would toughen training for tattoo artists > UPDATE 4-Dynavax shares soar as hepatitis B trials resume > Interferon Gene Variant Predicts Response to Hepatitis C Treatment > Celsion and the American Liver Foundation Partner to Promote Awareness of > Primary Liver Cancer and the ThermoDox Phase III Global HEAT Study to > Patients and Physicians > Editorial: Medical Inattention in New York Prisons > Physicians Are Talking About: The Million Med March on Washington > Engineering Team To Design And Study Liver Mimics > Aerobic Exercise Reduces Fatty Liver > ChemDiv And IDialog Nominate Novel Inhibitor Of Hepatitis C For Clinical > Development > Uninsured Americans hope reform brings health coverage > Hepatitis myths put Canadians at risk, survey warns > Genetic Hint for Ridding the Body of Hepatitis C > Are HBV Genotype B/B3 and C/C1 the Major Genotypes in Indonesia? > New Micro-Bland Embolization Technique with Embozene Microspheres to Be > Presented at the International Medical Conference in Lisbon, Portugal > Pa. approves over-the-counter syringe sales > Sticking it to the myths about hepatitis C > Researchers Isolates Liver Cancer Stem Cells Prior to Tumor Formation > Study links 45,000 U.S. deaths to lack of insurance > Give your kidneys a break: lose some weight > Cases of Liver Cancer Reduced in a Younger Population Vaccinated for HBV > Prime Minister Bayar Diagnosed to Have Hepatitis C > ICAAC: Hepatitis E Virus Finally Gets Some Respect > University Hospital Coventry unveils life-saving liver scanner > > *** Be sure to check out the latest event notices at both the HCV and HBV > Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not > reply to this email. Questions and/or comments can be directed to > alanfranciscus@ hcvadvocate. org > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 23, 2009 Report Share Posted September 23, 2009 Could someone please explain this to me. Is it just a site to go to in order to get the information thats listed. I guess I just don't understand, I feel stupid for asking but I don't know all the places to get info yet, other than here. Maybe if I read it in the morning it will make more since to me. Goodnight to all. Spots ________________________________ From: Glenn <grisley6315@...> Sent: Wednesday, September 23, 2009 9:48:36 PM Subject: Fwd: HCV Advocate Email Alert  > From: " www.hcvadvocate. org " <root@... te.org> > <emailalertlist (DOT) hcvadvocate. org> > Subject: HCV Advocate Email Alert > Date: Wed, 23 Sep 2009 16:06:26 -0400 > > > > Hello, > > The following items have been posted to www.hcvadvocate. org and > www.hbvadvocate. org. > > > > *** Hepatitis E (HEV) New! > > > > *** Short Term Disability Benefits New! > by Jacques Chambers, CLU, Benefits Consultant > > > *** Top 10 HCV Downloads of the Month (English & Spanish) New! > > *** Top 10 HBV Downloads of the Month New! > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > > Week Ending: September 19, 2009 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > Aspirin Could Diminish Hepatitis C Virus Replication > California bill would toughen training for tattoo artists > UPDATE 4-Dynavax shares soar as hepatitis B trials resume > Interferon Gene Variant Predicts Response to Hepatitis C Treatment > Celsion and the American Liver Foundation Partner to Promote Awareness of > Primary Liver Cancer and the ThermoDox Phase III Global HEAT Study to > Patients and Physicians > Editorial: Medical Inattention in New York Prisons > Physicians Are Talking About: The Million Med March on Washington > Engineering Team To Design And Study Liver Mimics > Aerobic Exercise Reduces Fatty Liver > ChemDiv And IDialog Nominate Novel Inhibitor Of Hepatitis C For Clinical > Development > Uninsured Americans hope reform brings health coverage > Hepatitis myths put Canadians at risk, survey warns > Genetic Hint for Ridding the Body of Hepatitis C > Are HBV Genotype B/B3 and C/C1 the Major Genotypes in Indonesia? > New Micro-Bland Embolization Technique with Embozene Microspheres to Be > Presented at the International Medical Conference in Lisbon, Portugal > Pa. approves over-the-counter syringe sales > Sticking it to the myths about hepatitis C > Researchers Isolates Liver Cancer Stem Cells Prior to Tumor Formation > Study links 45,000 U.S. deaths to lack of insurance > Give your kidneys a break: lose some weight > Cases of Liver Cancer Reduced in a Younger Population Vaccinated for HBV > Prime Minister Bayar Diagnosed to Have Hepatitis C > ICAAC: Hepatitis E Virus Finally Gets Some Respect > University Hospital Coventry unveils life-saving liver scanner > > *** Be sure to check out the latest event notices at both the HCV and HBV > Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not > reply to this email. Questions and/or comments can be directed to > alanfranciscus@ hcvadvocate. org > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 24, 2009 Report Share Posted September 24, 2009 Spots, The website, www.hcvadvocate.org, has tons of information. The titles listed in this email are just the new or highlighted ones. Anythng on the site can be downloaded and printed, if you keep Alan's logo on the material. There is material for the newly diagnosed, the patient for who treatment has failed, information for family and friends, info regarding disablity. Take a look, there is something for everyone. G > > Could someone please explain this to me. Is it just a site to go to in order to get the information thats listed. I guess I just don't understand, I feel stupid for asking but I don't know all the places to get info yet, other than here. Maybe if I read it in the morning it will make more since to me. Goodnight to all. > > Spots > > > > > ________________________________ > From: Glenn <grisley6315@...> > Sent: Wednesday, September 23, 2009 9:48:36 PM > Subject: Fwd: HCV Advocate Email Alert > > Â > > From: " www.hcvadvocate. org " <root@... te.org> > > <emailalertlist (DOT) hcvadvocate. org> > > Subject: HCV Advocate Email Alert > > Date: Wed, 23 Sep 2009 16:06:26 -0400 > > > > > > > > Hello, > > > > The following items have been posted to www.hcvadvocate. org and > > www.hbvadvocate. org. > > > > > > > > *** Hepatitis E (HEV) New! > > > > > > > > *** Short Term Disability Benefits New! > > by Jacques Chambers, CLU, Benefits Consultant > > > > > > *** Top 10 HCV Downloads of the Month (English & Spanish) New! > > > > *** Top 10 HBV Downloads of the Month New! > > > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > > > > Week Ending: September 19, 2009 > > > > Alan Franciscus > > Editor-in-Chief > > > > To download pdf version click here > > > > > > This Issue: > > > > Aspirin Could Diminish Hepatitis C Virus Replication > > California bill would toughen training for tattoo artists > > UPDATE 4-Dynavax shares soar as hepatitis B trials resume > > Interferon Gene Variant Predicts Response to Hepatitis C Treatment > > Celsion and the American Liver Foundation Partner to Promote Awareness of > > Primary Liver Cancer and the ThermoDox Phase III Global HEAT Study to > > Patients and Physicians > > Editorial: Medical Inattention in New York Prisons > > Physicians Are Talking About: The Million Med March on Washington > > Engineering Team To Design And Study Liver Mimics > > Aerobic Exercise Reduces Fatty Liver > > ChemDiv And IDialog Nominate Novel Inhibitor Of Hepatitis C For Clinical > > Development > > Uninsured Americans hope reform brings health coverage > > Hepatitis myths put Canadians at risk, survey warns > > Genetic Hint for Ridding the Body of Hepatitis C > > Are HBV Genotype B/B3 and C/C1 the Major Genotypes in Indonesia? > > New Micro-Bland Embolization Technique with Embozene Microspheres to Be > > Presented at the International Medical Conference in Lisbon, Portugal > > Pa. approves over-the-counter syringe sales > > Sticking it to the myths about hepatitis C > > Researchers Isolates Liver Cancer Stem Cells Prior to Tumor Formation > > Study links 45,000 U.S. deaths to lack of insurance > > Give your kidneys a break: lose some weight > > Cases of Liver Cancer Reduced in a Younger Population Vaccinated for HBV > > Prime Minister Bayar Diagnosed to Have Hepatitis C > > ICAAC: Hepatitis E Virus Finally Gets Some Respect > > University Hospital Coventry unveils life-saving liver scanner > > > > *** Be sure to check out the latest event notices at both the HCV and HBV > > Advocate websites > > > > HCV Events > > HBV Events > > > > > > Thanks! > > > > Alan Franciscus > > Executive Director, Hepatitis C Support Project > > Editor-in-Chief, HCV Advocate > > > > > > > > **Questions and Comments: If you have questions or comments please do not > > reply to this email. Questions and/or comments can be directed to > > alanfranciscus@ hcvadvocate. org > > > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 24, 2009 Report Share Posted September 24, 2009 Glenn, Thank you for the info. I haven't been feeling that great and have no been able to understand alot of things. Spots ________________________________ From: GlennR <grisley6315@...> Hepatitis C Sent: Thursday, September 24, 2009 11:04:28 AM Subject: Re: Fwd: HCV Advocate Email Alert  Spots, The website, www.hcvadvocate. org, has tons of information. The titles listed in this email are just the new or highlighted ones. Anythng on the site can be downloaded and printed, if you keep Alan's logo on the material. There is material for the newly diagnosed, the patient for who treatment has failed, information for family and friends, info regarding disablity. Take a look, there is something for everyone. G > > Could someone please explain this to me. Is it just a site to go to in order to get the information thats listed. I guess I just don't understand, I feel stupid for asking but I don't know all the places to get info yet, other than here. Maybe if I read it in the morning it will make more since to me. Goodnight to all. > > Spots > > > > > ____________ _________ _________ __ > From: Glenn <grisley6315@ ...> > Sent: Wednesday, September 23, 2009 9:48:36 PM > Subject: Fwd: HCV Advocate Email Alert > >  > > From: " www.hcvadvocate. org " <root@... te.org> > > <emailalert@ list. hcvadvocate. org> > > Subject: HCV Advocate Email Alert > > Date: Wed, 23 Sep 2009 16:06:26 -0400 > > > > > > > > Hello, > > > > The following items have been posted to www.hcvadvocate. org and > > www.hbvadvocate. org. > > > > > > > > *** Hepatitis E (HEV) New! > > > > > > > > *** Short Term Disability Benefits New! > > by Jacques Chambers, CLU, Benefits Consultant > > > > > > *** Top 10 HCV Downloads of the Month (English & Spanish) New! > > > > *** Top 10 HBV Downloads of the Month New! > > > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > > > > Week Ending: September 19, 2009 > > > > Alan Franciscus > > Editor-in-Chief > > > > To download pdf version click here > > > > > > This Issue: > > > > Aspirin Could Diminish Hepatitis C Virus Replication > > California bill would toughen training for tattoo artists > > UPDATE 4-Dynavax shares soar as hepatitis B trials resume > > Interferon Gene Variant Predicts Response to Hepatitis C Treatment > > Celsion and the American Liver Foundation Partner to Promote Awareness of > > Primary Liver Cancer and the ThermoDox Phase III Global HEAT Study to > > Patients and Physicians > > Editorial: Medical Inattention in New York Prisons > > Physicians Are Talking About: The Million Med March on Washington > > Engineering Team To Design And Study Liver Mimics > > Aerobic Exercise Reduces Fatty Liver > > ChemDiv And IDialog Nominate Novel Inhibitor Of Hepatitis C For Clinical > > Development > > Uninsured Americans hope reform brings health coverage > > Hepatitis myths put Canadians at risk, survey warns > > Genetic Hint for Ridding the Body of Hepatitis C > > Are HBV Genotype B/B3 and C/C1 the Major Genotypes in Indonesia? > > New Micro-Bland Embolization Technique with Embozene Microspheres to Be > > Presented at the International Medical Conference in Lisbon, Portugal > > Pa. approves over-the-counter syringe sales > > Sticking it to the myths about hepatitis C > > Researchers Isolates Liver Cancer Stem Cells Prior to Tumor Formation > > Study links 45,000 U.S. deaths to lack of insurance > > Give your kidneys a break: lose some weight > > Cases of Liver Cancer Reduced in a Younger Population Vaccinated for HBV > > Prime Minister Bayar Diagnosed to Have Hepatitis C > > ICAAC: Hepatitis E Virus Finally Gets Some Respect > > University Hospital Coventry unveils life-saving liver scanner > > > > *** Be sure to check out the latest event notices at both the HCV and HBV > > Advocate websites > > > > HCV Events > > HBV Events > > > > > > Thanks! > > > > Alan Franciscus > > Executive Director, Hepatitis C Support Project > > Editor-in-Chief, HCV Advocate > > > > > > > > **Questions and Comments: If you have questions or comments please do not > > reply to this email. Questions and/or comments can be directed to > > alanfranciscus@ hcvadvocate. org > > > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 30, 2009 Report Share Posted September 30, 2009 Good article on Swine Flu H1N1. I'll be getting both shots when they are available. Besides having cirrhosis, I don't have a spleen so my bouts with colds and the flu are worse than normal. > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Wed, 30 Sep 2009 20:02:22 -0400 > > > > Hello, > > The following items have been posted to www.hcvadvocate.org and www.hbvadvocate.org. > > > > *** HCV Advocate Newsletter: October 2009 > Download printable version > > In This Issue: > > Unlocking Interferon > Alan Franciscus, Editor-in-Chief > > Top 10 Post Counseling Messages > Alan Franciscus, Editor-in-Chief > , Hepatitis C Coordinator > Hawai`i Department of Health > > HealthWise: Swine Flu > Lucinda Porter, RN > > Treating Hepatitis C in Prison > Liz Highleyman > > Symptoms and Complications of Cirrhosis > Alan Franciscus, Editor-in-Chief > > > > *** HBV Journal Review: October 2009 > by Kukka > > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > > Week Ending: September 26, 2009 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > In This Issue: > > Depressing trends in liver transplants look set to continue > Health care Rx for N.Y. prisons > Hollis: Test can bring 'silent killer' into the light > New Guidelines Help Primary Care Doctors Treat Liver Transplant Recipients > Liver failure brings dilemma in possible death penalty case > Hepatoma: Deadly > Data Safety Monitoring Board Recommends Continuation of Celsion's Phase III ThermoDox® Study for Primary Liver Cancer > Risky Behaviors among Truckers Lead to Higher Rates of STIs Including Hepatitis C > Mediterranean diet trims the wallet > Hepatitis B Vaccine Fails in Half of all Celiac Patients: Is it Time to Re-evaluate Current Immunization Strategies? > Prisons can't contain rising medical costs > Lawyers: More cases of hepatitis discovered > Discovery could improve hepatitis C treatment > Hope for Hepatitis C patients: two new drugs on horizon > Shasta County supervisors extend needle exchange program > Unanimous support for free crack pipes plan > Everyone Should Be Tested for 'Hidden Disease' of Hepatitis C > The 60th Annual Meeting of the American Association for the Study of Liver Diseases > HCV: Wait for Something New or Treat Now? > Rockefeller virologists and MIT tissue engineers receive $5.8 million NIH grant to study hepatitis > Woman wins 'lonely battle' with infectious disease > Override Lynch's med marijuana veto > Vertex Pharmaceuticals Announces Publication of Telaprevir Abstracts for Presentation at the 60th AASLD Meeting > UW performs rare 2-for-1 'domino' transplant > Worker in Hepatitis Case Is Sentenced to 20 Years > > > *** Be sure to check out the latest event notices at both the HCV and HBV Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 1, 2009 Report Share Posted October 1, 2009 i would have to worry about the reaction you may get from the new H1N1 flu shot,i dont know...  glen,are you familar black cumin,link below... http://www.kitchendoctor.com/articles/blackcumin.html From: Glenn <grisley6315@...> Subject: Fwd: HCV Advocate Email Alert To: Date: Wednesday, September 30, 2009, 7:52 PM  Good article on Swine Flu H1N1. I'll be getting both shots when they are available. Besides having cirrhosis, I don't have a spleen so my bouts with colds and the flu are worse than normal. > From: " www.hcvadvocate. org " <root@... te.org> > <emailalertlist (DOT) hcvadvocate. org> > Subject: HCV Advocate Email Alert > Date: Wed, 30 Sep 2009 20:02:22 -0400 > > > > Hello, > > The following items have been posted to www.hcvadvocate. org and www.hbvadvocate. org. > > > > *** HCV Advocate Newsletter: October 2009 > Download printable version > > In This Issue: > > Unlocking Interferon > Alan Franciscus, Editor-in-Chief > > Top 10 Post Counseling Messages > Alan Franciscus, Editor-in-Chief > , Hepatitis C Coordinator > Hawai`i Department of Health > > HealthWise: Swine Flu > Lucinda Porter, RN > > Treating Hepatitis C in Prison > Liz Highleyman > > Symptoms and Complications of Cirrhosis > Alan Franciscus, Editor-in-Chief > > > > *** HBV Journal Review: October 2009 > by Kukka > > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > > Week Ending: September 26, 2009 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > In This Issue: > > Depressing trends in liver transplants look set to continue > Health care Rx for N.Y. prisons > Hollis: Test can bring 'silent killer' into the light > New Guidelines Help Primary Care Doctors Treat Liver Transplant Recipients > Liver failure brings dilemma in possible death penalty case > Hepatoma: Deadly > Data Safety Monitoring Board Recommends Continuation of Celsion's Phase III ThermoDox® Study for Primary Liver Cancer > Risky Behaviors among Truckers Lead to Higher Rates of STIs Including Hepatitis C > Mediterranean diet trims the wallet > Hepatitis B Vaccine Fails in Half of all Celiac Patients: Is it Time to Re-evaluate Current Immunization Strategies? > Prisons can't contain rising medical costs > Lawyers: More cases of hepatitis discovered > Discovery could improve hepatitis C treatment > Hope for Hepatitis C patients: two new drugs on horizon > Shasta County supervisors extend needle exchange program > Unanimous support for free crack pipes plan > Everyone Should Be Tested for 'Hidden Disease' of Hepatitis C > The 60th Annual Meeting of the American Association for the Study of Liver Diseases > HCV: Wait for Something New or Treat Now? > Rockefeller virologists and MIT tissue engineers receive $5.8 million NIH grant to study hepatitis > Woman wins 'lonely battle' with infectious disease > Override Lynch's med marijuana veto > Vertex Pharmaceuticals Announces Publication of Telaprevir Abstracts for Presentation at the 60th AASLD Meeting > UW performs rare 2-for-1 'domino' transplant > Worker in Hepatitis Case Is Sentenced to 20 Years > > > *** Be sure to check out the latest event notices at both the HCV and HBV Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@ hcvadvocate. org > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 21, 2009 Report Share Posted October 21, 2009 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Wed, 21 Oct 2009 13:53:02 -0400 > > > > Hello, > > The following items have been posted to www.hcvadvocate.org and www.hbvadvocate.org. > > > > *** Action Alert > Help ensure that the NHAS fully addresses people living with and at-risk for both HIV and viral hepatitis by voicing your concerns at the community discussion. > > > > *** World Hepatitis Alliance 2010 Communications Plan > Where Are We Now? The Five Year Plan, Two Years In. > > > > *** Speeding Up Your Social Security Claim, by Jacques Chamber, CLU > Getting Social Security to make a decision on a claim for disability has never been a rapid process, however, it is now taking even longer. Claims for disability have increased dramatically, but the staff at Social Security has not. > > > > *** Take the HBV Quiz > Be sure to check out our latest interactive learning tool > > > *** Top 10 HCV Downloads of the Month (English & Spanish) > > *** Top 10 HBV Downloads of the Month > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > > Week Ending: Octber 17, 2009 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > AIDS, Hepatitis C Cases Increasing in Montana > B Here Raises Awareness for UCI > Alert Over Donor Organs Riddled with Cancer, Mad Cow Disease and Hepatitis > Haemophiliacs with HIV to Sue Firm that Sold Tainted Drug in Asia > China to Stop Mandatory Hepatitis B Tests: State Media > DPP Refuses to Reveal Reason for Dropping Hep C Charges > When Good Medical Care is All or Something > Endoscopy Plaintiffs Target Drug Suppliers > UCSD Researchers Pave the Way for Effective Liver Treatments > Report Calls for Global U.N. Pact to Ban Organ Sales > Liver Stiffness Scan Shows Cirrhosis > Hospital in Milan, Illinois to Help Pay for Hepatitis-A Shots > Keep Body's 'Chemical Plant' in Good Working Order > Cyplasin Biomedical Ltd., Announces Hepatitis C Product Licensing Deal > Schering-Plough Highlights Boceprevir, Narlaprevir (SCH 900518) and PEGINTRON® Data at the American Association for the Study of Liver Diseases (AASLD) 2009 Annual Meeting > Aethlon Medical to Present Data on HVC Patients Treated with its Hemopurifier at the 42nd ASN Meeting > Women with HIV Co-Infected with Hepatitis B or C Have Increased Risk of Bone Problems > Former Drug Addict Urges More to Take Hepatitis Test > Subaru Donates 'Hep B Hero Mobile' to Support Campaign > Florida Hospital Confirms Patients Infected by Reused IV Bags > Website Warns Asian Community of Hepatitis C Dangers > CAMP Rehoboth to Offer Free Hepatitis Vaccinations > Race for a Cause: Hepatitis C > > *** Be sure to check out the latest event notices at both the HCV and HBV Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 18, 2009 Report Share Posted November 18, 2009 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Wed, 18 Nov 2009 16:43:58 -0500 > > > > Hello, > > The following items have been posted to www.hcvadvocate.org and > www.hbvadvocate.org. > > > > *** AASLD 2009 HCV Coverage > Check this link daily for onsite updates on posters and presentations from > this year's conference. > > > > *** Special Presentation: Combination Therapy With A Nucleoside Polymerase > (RG7128) And Protease (RG7227/ITMN ITMN-191) Inhibitor In HCV: Safety, > Pharmacokinetics, And Virologic Results From INFORM INFORM-1 > > > > *** Healthcare Reform, by Jacques Chambers, CLU > Be sure to check out this insightful review of main issues under discussion > > > > > *** Top 10 Downloads of the Month > > HCV > HBV > > > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > > Week Ending: November 14, 2009 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > AASLD: HCV-Related News > AASLD: HBV-Related News > Giving Back: Greenview > Brookline, Lexington Students Advance in National Contest > Prison Hep C Problem Will Cost Millions, MPs Told > Bill Would Limit Needle Exchanges > Doc Offers Top Hep C Drug Picks: BioBuzz > A Life-Changing Liver Transplant > Patients with More Difficult to Treat Forms of Hepatitis C Are Half as > Likely to Treat the Disease > Costrini: Advances in Hepatitis C Care Improve Odds of Cure > Aduro Biotech Completes Series A-1 Financing > A New Solution to Liver Disease Detection > NVHR: New JAMA Article Underscores Urgent Need for Congress to Act on > Viral Hepatitis Detection, Management Funding > Largest-Ever Database for Liver Proteins May Lead to Treatments for > Hepatitis > Stigma and Hepatitis C > Sexual Transmission Blamed for High HBV Infection Rate > Boy and Sadie Frost Back Hepatitis C Campaign > Bankruptcy Trustee: Leave the Hepatitis Claims to Us > Tamara Browning: Donor Sabbath Scheduled Sunday > Roseburg's Harm Reduction Center Holding Fundraiser > Government Hepatitis Liability Ends with $44 K Payout to Veteran > > > *** Be sure to check out the latest event notices at both the HCV and HBV > Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not > reply to this email. Questions and/or comments can be directed to > alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 18, 2009 Report Share Posted November 18, 2009 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Wed, 18 Nov 2009 16:43:58 -0500 > > > > Hello, > > The following items have been posted to www.hcvadvocate.org and > www.hbvadvocate.org. > > > > *** AASLD 2009 HCV Coverage > Check this link daily for onsite updates on posters and presentations from > this year's conference. > > > > *** Special Presentation: Combination Therapy With A Nucleoside Polymerase > (RG7128) And Protease (RG7227/ITMN ITMN-191) Inhibitor In HCV: Safety, > Pharmacokinetics, And Virologic Results From INFORM INFORM-1 > > > > *** Healthcare Reform, by Jacques Chambers, CLU > Be sure to check out this insightful review of main issues under discussion > > > > > *** Top 10 Downloads of the Month > > HCV > HBV > > > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > > Week Ending: November 14, 2009 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > AASLD: HCV-Related News > AASLD: HBV-Related News > Giving Back: Greenview > Brookline, Lexington Students Advance in National Contest > Prison Hep C Problem Will Cost Millions, MPs Told > Bill Would Limit Needle Exchanges > Doc Offers Top Hep C Drug Picks: BioBuzz > A Life-Changing Liver Transplant > Patients with More Difficult to Treat Forms of Hepatitis C Are Half as > Likely to Treat the Disease > Costrini: Advances in Hepatitis C Care Improve Odds of Cure > Aduro Biotech Completes Series A-1 Financing > A New Solution to Liver Disease Detection > NVHR: New JAMA Article Underscores Urgent Need for Congress to Act on > Viral Hepatitis Detection, Management Funding > Largest-Ever Database for Liver Proteins May Lead to Treatments for > Hepatitis > Stigma and Hepatitis C > Sexual Transmission Blamed for High HBV Infection Rate > Boy and Sadie Frost Back Hepatitis C Campaign > Bankruptcy Trustee: Leave the Hepatitis Claims to Us > Tamara Browning: Donor Sabbath Scheduled Sunday > Roseburg's Harm Reduction Center Holding Fundraiser > Government Hepatitis Liability Ends with $44 K Payout to Veteran > > > *** Be sure to check out the latest event notices at both the HCV and HBV > Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not > reply to this email. Questions and/or comments can be directed to > alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 1, 2009 Report Share Posted December 1, 2009 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Tue, 1 Dec 2009 15:51:09 -0500 > > > > HCV ADVOCATE EBLAST > December 1, 2009 > > > Hello, > > The following items have been posted to www.hcvadvocate.org and www.hbvadvocate.org . > > > > ***HCV Advocate Newsletter: December 2009 > Download printable version > In This Issue: > > AASLD 2009 - Part 1 > Alan Franciscus, Editor-in-Chief > > HealthWise: Hepatitis C Update > Lucinda Porter, RN > > How Do Targeted Anti-HCV Drugs Work? > Liz Highleyman > > Jamalot > C.D. Mazoff, PhD, Managing Editor/Webmaster > > HCV among Truck Drivers > Alan Franciscus, Editor-in-Chief > > > > ***Hepatitis Journal Review : November 2009 > by Liz Highleyman > To download pdf version click here > > In This Issue: > > Acute vs. Chronic HCV Diagnosis > Spontaneous HCV Clearance in Children > Treatment Response in Older Patients > Retreatment of Nonresponders > > Response and Relapse in HIV/HCV Coinfected Patients > Coinfection with Advanced Immune Suppression > > > > ***HBV Journal Review : December 2009 > by Kukka > > > > *** Medicare Annual Enrollment > Between November 15 and December 31, if you are on Medicare you can: > > Change from Original Medicare to a Medicare Advantage Plan. > Change from a Medicare Advantage Plan back to Original Medicare. > Switch from one Medicare Advantage Plan to another Medicare Advantage Plan. > > Read more...................... > > > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > Week Ending: November 28, 2009 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > Backed by House, 6 patients sue Pawlenty, state officials > Increasing Long-Term Survival in Patients with Severe Liver Cancer > Diet Rich in Processed Food Linked to Increased Risk for Depression > My View: Ignoring Prisoners' Health Imperils Community > Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C > Antiviral Therapy for Hepatitis C Appears To Be Declining in the U.S.; Lack of Diagnosis Is Primary Barrier to Treatment > Advanced Hepatitis Drug Nears FDA Approval > NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients Receiving Antiviral Therapy is 'Wake-Up Call' for Washington to Act > Women's Health: Combating a Common Virus > Vitamin D Boosts Treatment of Chronic Hepatitis C > Human Genome Sciences Submits BLA to FDA for ZALBIN for Chronic Hepatitis C > Scientists See Little Difference in Survival Rates between Non-Alcoholic and Alcoholic Liver Transplants > Tips for Managing the Flu with Liver Disease > Metobolomics Uncovers Key Indicators of Nonalcoholic Fatty Liver Disease > New Data Emerges on Liver Transplant Survival Rates > Needle Sticks Can Be a Job Hazard for Medical Students > Future of Maine's Needle Exchange Programs in Doubt > Vibrating Technology Promises to Replace Biopsies in Diagnosing Diseased Tissue > Tripep: The ChronVac-C® Study Has Been Successfully Completed with Good Safety and Favorable Clinical Data > With Jesper Mattsson > > > *** Be sure to check out the latest event notices at both the HCV and HBV Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 1, 2009 Report Share Posted December 1, 2009 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Tue, 1 Dec 2009 15:51:09 -0500 > > > > HCV ADVOCATE EBLAST > December 1, 2009 > > > Hello, > > The following items have been posted to www.hcvadvocate.org and www.hbvadvocate.org . > > > > ***HCV Advocate Newsletter: December 2009 > Download printable version > In This Issue: > > AASLD 2009 - Part 1 > Alan Franciscus, Editor-in-Chief > > HealthWise: Hepatitis C Update > Lucinda Porter, RN > > How Do Targeted Anti-HCV Drugs Work? > Liz Highleyman > > Jamalot > C.D. Mazoff, PhD, Managing Editor/Webmaster > > HCV among Truck Drivers > Alan Franciscus, Editor-in-Chief > > > > ***Hepatitis Journal Review : November 2009 > by Liz Highleyman > To download pdf version click here > > In This Issue: > > Acute vs. Chronic HCV Diagnosis > Spontaneous HCV Clearance in Children > Treatment Response in Older Patients > Retreatment of Nonresponders > > Response and Relapse in HIV/HCV Coinfected Patients > Coinfection with Advanced Immune Suppression > > > > ***HBV Journal Review : December 2009 > by Kukka > > > > *** Medicare Annual Enrollment > Between November 15 and December 31, if you are on Medicare you can: > > Change from Original Medicare to a Medicare Advantage Plan. > Change from a Medicare Advantage Plan back to Original Medicare. > Switch from one Medicare Advantage Plan to another Medicare Advantage Plan. > > Read more...................... > > > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > Week Ending: November 28, 2009 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > Backed by House, 6 patients sue Pawlenty, state officials > Increasing Long-Term Survival in Patients with Severe Liver Cancer > Diet Rich in Processed Food Linked to Increased Risk for Depression > My View: Ignoring Prisoners' Health Imperils Community > Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C > Antiviral Therapy for Hepatitis C Appears To Be Declining in the U.S.; Lack of Diagnosis Is Primary Barrier to Treatment > Advanced Hepatitis Drug Nears FDA Approval > NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients Receiving Antiviral Therapy is 'Wake-Up Call' for Washington to Act > Women's Health: Combating a Common Virus > Vitamin D Boosts Treatment of Chronic Hepatitis C > Human Genome Sciences Submits BLA to FDA for ZALBIN for Chronic Hepatitis C > Scientists See Little Difference in Survival Rates between Non-Alcoholic and Alcoholic Liver Transplants > Tips for Managing the Flu with Liver Disease > Metobolomics Uncovers Key Indicators of Nonalcoholic Fatty Liver Disease > New Data Emerges on Liver Transplant Survival Rates > Needle Sticks Can Be a Job Hazard for Medical Students > Future of Maine's Needle Exchange Programs in Doubt > Vibrating Technology Promises to Replace Biopsies in Diagnosing Diseased Tissue > Tripep: The ChronVac-C® Study Has Been Successfully Completed with Good Safety and Favorable Clinical Data > With Jesper Mattsson > > > *** Be sure to check out the latest event notices at both the HCV and HBV Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 10, 2009 Report Share Posted December 10, 2009 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Thu, 10 Dec 2009 15:48:27 -0500 > > > > HCV ADVOCATE EBLAST > December 10, 2009 > > > Hello, > > The following items have been posted to www.hcvadvocate.org and > www.hbvadvocate.org. > > > > DRUGS > IN DEVELOPMENT > > Be sure to check out the latest developments in the HCV Drug Pipeline: > Click here. > > > > FACTSHEETS > > Disease Progression: Symptoms and Complications of Cirrhosis > HCV Education & Support: Top 10 Counseling Messages > Bulgarian Translation of HCSP HCV Factsheets > Bulgarian Translation of HCSP HBV Factsheets > > > > WEEKLY NEWS REVIEW > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > Week Ending: December 5, 2009 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > What Happens When Doctors Give Patients More Power? > The ABCs of Hepatitis > Law to Offer Comprehensive Relief to Hepatitis Patients Enacted > HCV Infection Tied to Increased Mortality in HIV+ Patients During HAART Era > > New Guidelines on Reporting Industry-Supported Clinical Trial Results > Former Army Nurse Gets Prison in Hepatitis C Case > Fine Levied against Illegal Tattooist > Metabolic Syndrome Prevalent after Liver Transplant > New Hepatitis C Treatment Shows Promise > Reused Syringe Victims Eye Insurers in Vegas > Diclofenac Linked to Liver Failure, Death > > > > EVENTS > > *** Be sure to check out the latest event notices at both the HCV and HBV > Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not > reply to this email. Questions and/or comments can be directed to > alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 10, 2009 Report Share Posted December 10, 2009 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Thu, 10 Dec 2009 15:48:27 -0500 > > > > HCV ADVOCATE EBLAST > December 10, 2009 > > > Hello, > > The following items have been posted to www.hcvadvocate.org and > www.hbvadvocate.org. > > > > DRUGS > IN DEVELOPMENT > > Be sure to check out the latest developments in the HCV Drug Pipeline: > Click here. > > > > FACTSHEETS > > Disease Progression: Symptoms and Complications of Cirrhosis > HCV Education & Support: Top 10 Counseling Messages > Bulgarian Translation of HCSP HCV Factsheets > Bulgarian Translation of HCSP HBV Factsheets > > > > WEEKLY NEWS REVIEW > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > Week Ending: December 5, 2009 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > What Happens When Doctors Give Patients More Power? > The ABCs of Hepatitis > Law to Offer Comprehensive Relief to Hepatitis Patients Enacted > HCV Infection Tied to Increased Mortality in HIV+ Patients During HAART Era > > New Guidelines on Reporting Industry-Supported Clinical Trial Results > Former Army Nurse Gets Prison in Hepatitis C Case > Fine Levied against Illegal Tattooist > Metabolic Syndrome Prevalent after Liver Transplant > New Hepatitis C Treatment Shows Promise > Reused Syringe Victims Eye Insurers in Vegas > Diclofenac Linked to Liver Failure, Death > > > > EVENTS > > *** Be sure to check out the latest event notices at both the HCV and HBV > Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not > reply to this email. Questions and/or comments can be directed to > alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 19, 2010 Report Share Posted January 19, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Tue, 19 Jan 2010 22:05:06 -0500 > > > > HCV ADVOCATE EBLAST > January 19, 2010 > > > Hello, > > The following items have been posted to www.hcvadvocate.org and www.hbvadvocate.org. > > > > E-Alert from WHA > > An important message from the World Hepatitis Alliance concerning World Hepatitis Day 2010 > > > > Top 10 Downloads > > Top 10 HepB Downloads of the Month (January 2010) > Check out what everyone has been reading > > Top 10 HCV Downloads of the Month / Las 10 descargas más frecuentes del mes -- Updated January 2010 > HCSP publishes a variety of Educational Materials which you can download and use in your community. Each month we will post the top 10 downloads of the month, for both English and Spanish. > > > > WEEKLY NEWS REVIEW > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > Week Ending: January 16, 2010 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > > Treatment of Hepatitis C within a Methadone Maintenance Program Yields Results Comparable to Treatment via Other Models of Care > The Hepatitis C Generation: Are Baby Boomers More Prone To Hepatitis C? > Hepatitis C Group Launches to Aid Thousands of Edinburgh Victims > After Years of Drugs, Stealing Dayton Native Turned Life Around, Became Nurse > Achillion Announces Additional Positive Phase 1b Data with ACH-1625 to Treat Hepatitis C > Idenix Pharmaceuticals Highlights Progress in Three HCV Programs > Vertex to Ask for Telaprevir OK Later in 2010 > My Turn: What Happens after Hepatitis > Human Genome Sciences Reports Increasing Momentum toward Commercialization > Reinfection after Liver Transplantation > Virtual Liver Offers Better Chance of Life > Coffee Cuts Liver Scarring in Hepatitis C > Hepatitis B and C Often Ignored as Health Threat to Blacks > IOM & Viral Hepatitis > IOM Recommends National Strategy for Hepatitis B and C > InterMune Updates Development Program of Protease Inhibitor RG7227 for Treatment of Hepatitis C - Update > Liver Lines > Mayor Newsom Convenes Task Force to Address Hepatitis C Epidemic > field Officer Kurt Beach Wants Workers' Compensation Law Changed > Doctor: Drug War Waged against Wrong People > A Novel and Simple Formula to Predict Treatment Success in Chronic Hepatitis C > Hepatitis E: A Public Health Concern > New HIV and Hepatitis C Treatment Centre Opens in Waterloo > AASLD Applauds Landmark IOM Study That Shows the Path to Eradicate Hepatitis B and C > Government Appoints New Clinical Director for Liver Diseases > Tylenol, Motrin, Benadryl, St. ph Aspirin, Rolaids Recall > HCV Found in Carotid Atherosclerosis Plaques of Chronic Hepatitis C Patients > Canadian Safe-Injection Site to Remain Open > Adding Ketoprofen to Treatment for Chronic Hepatitis C: A Phase II Study > > > > EVENTS > > *** Be sure to check out the latest event notices at both the HCV and HBV Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 19, 2010 Report Share Posted January 19, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Tue, 19 Jan 2010 22:05:06 -0500 > > > > HCV ADVOCATE EBLAST > January 19, 2010 > > > Hello, > > The following items have been posted to www.hcvadvocate.org and www.hbvadvocate.org. > > > > E-Alert from WHA > > An important message from the World Hepatitis Alliance concerning World Hepatitis Day 2010 > > > > Top 10 Downloads > > Top 10 HepB Downloads of the Month (January 2010) > Check out what everyone has been reading > > Top 10 HCV Downloads of the Month / Las 10 descargas más frecuentes del mes -- Updated January 2010 > HCSP publishes a variety of Educational Materials which you can download and use in your community. Each month we will post the top 10 downloads of the month, for both English and Spanish. > > > > WEEKLY NEWS REVIEW > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > Week Ending: January 16, 2010 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > > Treatment of Hepatitis C within a Methadone Maintenance Program Yields Results Comparable to Treatment via Other Models of Care > The Hepatitis C Generation: Are Baby Boomers More Prone To Hepatitis C? > Hepatitis C Group Launches to Aid Thousands of Edinburgh Victims > After Years of Drugs, Stealing Dayton Native Turned Life Around, Became Nurse > Achillion Announces Additional Positive Phase 1b Data with ACH-1625 to Treat Hepatitis C > Idenix Pharmaceuticals Highlights Progress in Three HCV Programs > Vertex to Ask for Telaprevir OK Later in 2010 > My Turn: What Happens after Hepatitis > Human Genome Sciences Reports Increasing Momentum toward Commercialization > Reinfection after Liver Transplantation > Virtual Liver Offers Better Chance of Life > Coffee Cuts Liver Scarring in Hepatitis C > Hepatitis B and C Often Ignored as Health Threat to Blacks > IOM & Viral Hepatitis > IOM Recommends National Strategy for Hepatitis B and C > InterMune Updates Development Program of Protease Inhibitor RG7227 for Treatment of Hepatitis C - Update > Liver Lines > Mayor Newsom Convenes Task Force to Address Hepatitis C Epidemic > field Officer Kurt Beach Wants Workers' Compensation Law Changed > Doctor: Drug War Waged against Wrong People > A Novel and Simple Formula to Predict Treatment Success in Chronic Hepatitis C > Hepatitis E: A Public Health Concern > New HIV and Hepatitis C Treatment Centre Opens in Waterloo > AASLD Applauds Landmark IOM Study That Shows the Path to Eradicate Hepatitis B and C > Government Appoints New Clinical Director for Liver Diseases > Tylenol, Motrin, Benadryl, St. ph Aspirin, Rolaids Recall > HCV Found in Carotid Atherosclerosis Plaques of Chronic Hepatitis C Patients > Canadian Safe-Injection Site to Remain Open > Adding Ketoprofen to Treatment for Chronic Hepatitis C: A Phase II Study > > > > EVENTS > > *** Be sure to check out the latest event notices at both the HCV and HBV Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 1, 2010 Report Share Posted February 1, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Mon, 1 Feb 2010 15:16:45 -0500 > > > > HCV ADVOCATE EBLAST > February 1 , 2010 > > > Hello, > > The following items have been posted to www.hcvadvocate.org and www.hbvadvocate.org. > > > > HCV ADVOCATE NEWSLETTER > > February 2010 HCV Advocate > > Download printable version > > In This Issue: > > IOM Report > Alan Franciscus, Editor-in-Chief > HealthWise: Milk Thistle > Lucinda Porter, RN > HCV Drug Resistance > Liz Highleyman > Disability & Benefits: Social Security and Blue Book Listings > Jacques Chambers, CLU > > > > JOURNAL REVIEW > > HBV JOURNAL REVIEW: > > February 1 , 2010 > Volume 7, Issue 2 > M. Kukka > > > DRUG PIPELINE > > Hepatitis C Treatments in Current Clinical Development - Updated February 1, 2010 > > > FACT SHEETS > > Hepatitis B > > Easy B's > > What is Cirrhosis? > Diet > Feeling Tired > Gay Men, Sex & HBV > > Hepatitis B Basics > > Patient Assistance Programs > > > > WEEKLY NEWS REVIEW > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > Week Ending: January 30, 2010 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > > Real-World Treatment Patterns, Non-Adherence, and Costs in Chronic Hepatitis C > There Must Be a Place in the Guinness Book for Jette > Paradigm Shift in Hepatitis C Testing May Curb the Numbers Affected, Says Expert > Unequal Outcomes despite Equal Treatment > Engineering a New Way to Study Hepatitis C > Dynavax Reports Positive Phase 1b Data for SD-101 in Chronic Hepatitis C Infection > 18 Hepatitis Cases to Be Settled > Beyond the Ice: Technique for Preserving Pre-Transplant Livers Promises to Improve Patient Outcomes and Expand the Organ Pool > Proposed Study for Liver Cancer Previewed at Interventional Oncology Meeting > Don't Fatten Your Liver > Health Tragedy: Patients Denied Life-Saving Transplants for Their " Abuse of Illicit Substances " > NVHR Issues Challenge to Administration, Congress: Don't Leave 5 Million Americans Afflicted with Chronic Viral Hepatitis out in the Cold with Budget Freeze > Tripep: Follow up of ChronVac-C®-Study with a 5th Dose Commenced > Liver Transplants Do Not Impair Immune Response in HIV/HCV Coinfected Patients > Race Team Promotes Hepatitis C Awareness > Achillion Announces Nomination of ACH-2684 as Lead Clinical Candidate in Resistance-Focused HCV Program > Barlow Bill Grows out of Kurt Beach's Experience > Coffee Break Boosts Memory > Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination with Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV) > Allegheny General Hospital Liver Transplant Program Certified > Catholic Charities to Give Syringes to Drug Users > Cancer in Remission, Now Comic Schimmel Needs a Liver Transplant > > > > EVENTS > > *** Be sure to check out the latest event notices at both the HCV and HBV Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 24, 2010 Report Share Posted February 24, 2010 > From: " www.hcvadvocate.org " <root@...> > <emailalert@...> > Subject: HCV Advocate Email Alert > Date: Wed, 24 Feb 2010 15:20:35 -0500 > > > > HCV ADVOCATE EBLAST > February 24 , 2010 > > > > > Hello, > > The following items have been posted to www.hcvadvocate.org and www.hbvadvocate.org. > > > > JOURNAL REVIEW > > Hepatitis Journal Review: Vol 7 no 2; February 2010 > by Liz Highleyman > In This Issue: > > Shorter Treatment for HCV Genotype 1? > HCV Found in Atherosclerosis Plaques > Kidney Disease in HIV/HCV Coinfection > Treatment of Injection Drug Users > Partial Immunity to HCV? > > > > DRUG PIPELINE > > Hepatitis C Treatments in Current Clinical Development - Updated February 15, 2010 > > > > FACT SHEETS > > Hepatitis B > > Easy B's > > Help with Medicines February 2010 > Medication Guide February 2010 > Taking HBV Medicines February 2010 > Herbs February 2010 > The Immune System February 2010 > Natural and Alternative Medicine February 2010 > Sleep February 2010 > Liver Cancer February 2010 > > > > Hepatitis C > > Easy C's > > New Hep C Medicines February 2010 > > Hepatitis C Basics > > Living with Hepatitis C: Managing Common Symptoms February 2010 > > Hepatitis Fact Series > > Tips for Lowering Prescription Drug Costs February 2010 > > > > Hepatitis C (Spanish) > > Datos Sencillos sobre la C > > ¿Qué es la Hepatitis C? (What is Hepatitis C?) Actualizado Febrero 2010 > Latinos (Latinos) Actualizado Febrero 2010 > Biopsia Hepática (Liver Biopsy) Actualizado Febrero 2010 > Dieta y Hepatitis C (Diet and Hepatitis C) Actualizado Febrero 2010 > Sueño y Hepatitis C (Sleep and Hepatitis C)Actualizado Febrero 2010 > Perforaciones Corporales y VHC (Piercing) Actualizado Febrero 2010 > Control de los Efectos Secundarios (Managing Side Effects) Actualizado Febrero 2010 > > > > Top 10 Downloads > > Top 10 HepB Downloads of the Month (February 2010) > Check out what everyone has been reading > > Top 10 HCV Downloads of the Month / Las 10 descargas más frecuentes del mes -- February 2010 > HCSP publishes a variety of Educational Materials which you can download and use in your community. Each month we will post the top 10 downloads of the month, for both English and Spanish. > > > > WEEKLY NEWS REVIEW > > *** HCV ADVOCATE WEEKLY NEWS REVIEW: > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights > Week Ending: February 20, 2010 > > Alan Franciscus > Editor-in-Chief > > To download pdf version click here > > > This Issue: > > Certain Syringes More Likely to Spread Hepatitis C Virus among Drug Users > Scioto County Ranks First in Hepatitis C Cases > Transfusion Victim Fights for Pay-Out > Survey of HBsAg-Positive Pregnant Women and Their Infants Regarding Measures to Prevent Maternal-Infantile Transmission > Erythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranesp: Drug Safety Communication > SHEA Releases Guidelines on Management of Healthcare Workers Infected with Hepatitis, HIV > Group Advocates Hepatitis C Education > Bill Would Ease Ban on Selling Syringes > Congress Considers Banning Medical Experiments on Chimpanzees > Pharmasset Announces Complete Enrollment of RG7128 Phase 2b Clinical Study > Dynavax Receives Canadian Approval to Conduct Phase 3 Trials of HEPLISAVT > FDA Warns of Maalox Mix-up Danger > Transplants Can Give Cirrhosis Patients a Brand-New Start, but Supply of Liver Donors Is Short > Guitar Legend Reveals Virus Shock > The Lack of Needles and the Damage Done > Clinic's Patients Warned of Hepatitis C Outbreak > Drug Diversion Needs More Compliance Attention; Hospital Technician Is Heading to Prison > 'Right to Know' Bill Would Impact Inmates with Diseases > > > > EVENTS > > *** Be sure to check out the latest event notices at both the HCV and HBV Advocate websites > > HCV Events > HBV Events > > > Thanks! > > Alan Franciscus > Executive Director, Hepatitis C Support Project > Editor-in-Chief, HCV Advocate > > > > **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... > > **Unsubscribe Information: Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.